Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.
about
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters.In Silico Modeling for the Prediction of Dose and Pathway-Related Adverse Effects in Humans From In Vitro Repeated-Dose Studies.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1.
P2860
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clarithromycin substantially i ...... xposure in healthy volunteers.
@en
Clarithromycin substantially i ...... xposure in healthy volunteers.
@nl
type
label
Clarithromycin substantially i ...... xposure in healthy volunteers.
@en
Clarithromycin substantially i ...... xposure in healthy volunteers.
@nl
prefLabel
Clarithromycin substantially i ...... xposure in healthy volunteers.
@en
Clarithromycin substantially i ...... xposure in healthy volunteers.
@nl
P2093
P2860
P50
P356
P1476
Clarithromycin substantially i ...... xposure in healthy volunteers.
@en
P2093
Christoph Markert
Johanna Weiss
Klaus-Dieter Riedel
Regina Hellwig
Theresia Wirsching
Yvonne Schweizer
P2860
P304
P356
10.1111/BCP.12177
P407
P577
2014-01-01T00:00:00Z